Colin Goodchild
2 SlideShares 1 Seguidor 7 Siguiendos
Personal Information
Organización/Lugar de trabajo
Malvern, Victoria Australia
Ocupación
Executive Director, Chief Medical Officer
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
wwwdrawbridgepharmaceuticals.com.au
Acerca de
Drawbridge was founded in 2011. It is a privately-held company with headquarters in Melbourne, Australia. Drawbridge is developing neuroactive steroid compounds for use in critical care situations in which protection of the brain from insult is required. Phaxan™ is the lead compound for use as a fast onset and offset intravenous general anaesthetic and sedative that causes neuroprotection. 
Datos de contacto
Etiquetas
procedural sedation intensive care sedation intravenous anaesthetic alphaxalone anaesthesia water soluble intravenous anaesthetic cyclodextrin therapeutic index alfaxalone phaxan water soluble anaesthetic anaesthetic
Ver más
Personal Information
Organización/Lugar de trabajo
Malvern, Victoria Australia
Ocupación
Executive Director, Chief Medical Officer
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
wwwdrawbridgepharmaceuticals.com.au
Acerca de
Drawbridge was founded in 2011. It is a privately-held company with headquarters in Melbourne, Australia. Drawbridge is developing neuroactive steroid compounds for use in critical care situations in which protection of the brain from insult is required. Phaxan™ is the lead compound for use as a fast onset and offset intravenous general anaesthetic and sedative that causes neuroprotection. 
Etiquetas
procedural sedation intensive care sedation intravenous anaesthetic alphaxalone anaesthesia water soluble intravenous anaesthetic cyclodextrin therapeutic index alfaxalone phaxan water soluble anaesthetic anaesthetic
Ver más